Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients [Phase 4]
Phase 4 trial evaluating triple blockade of the renin-angiotensin-aldosterone system in proteinuric diabetic patients (Type 1 and Type 2) ha…
-
CLINICAL_TRIALS research · 2013-10-23Clinical Trial Update: Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating dendritic cell therapy for Type 1 diabetes mellitus; the current status is unknown.
-
FDA approval · 2013-10-18FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-Aventis U.S. LLC. This action approves changes to…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia [NA]
A completed clinical trial investigated whether terbutaline use or reducing basal insulin can prevent nocturnal hypoglycemia in type 1 diabe…
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: Closing the Loop in Youth With Type 1 Diabetes in the Home Setting [Phase 2]
Phase 2 clinical trial update on a home-based closed-loop system for youth with Type 1 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: Rule-Based Closed Loop System for Type 1 Diabetes Control [NA]
The document reports the completion of a clinical trial evaluating a rule-based closed-loop system for managing blood glucose in individuals…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia [Phase 1]
Completed Phase 1 feasibility study evaluating whether an insulin pump–controlling algorithm can minimize hypoglycemia in people with Type 1…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes [Phase 2]
A Phase 2 trial evaluating an autoimmunity-blocking antibody for tolerance in recently diagnosed Type 1 diabetes has completed, with results…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia [NA]
A completed clinical trial comparing Apidra (insulin glulisine) to Humalog (insulin lispro) for reducing post-prandial hyperglycemia in Type…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System Efficacy (France) [NA]
Update on the completed early feasibility study 2 evaluating an outpatient control-to-range testing system for efficacy in Type 1 diabetes m…
-
FDA approval · 2013-09-06FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-09-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, expanding the regulatory approval for the product.
-
FDA approval · 2013-08-21FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro (and its diluent) from Eli Lilly, signaling an update to the product's regulatory…
-
FDA approval · 2013-08-21FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus [Phase 1]
A Phase 1 repeated-dose study in Japanese patients with Type 1 diabetes evaluated a new insulin glargine formulation alongside Lantus on 24-…
-
FDA approval · 2013-08-15FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA granted supplemental approval for insulin lispro from Eli Lilly (BLA020563), updating the product's regulatory status.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-08-15FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) to incorporate the KwikPen delivery device for the pre…
-
FDA approval · 2013-08-14FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus [Phase 1]
A phase 1 euglycemic clamp study comparing two insulin glargine formulations in adults with Type 1 diabetes was completed.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia
A completed clinical trial update examining how VLDL-triglyceride metabolism behaves during acute hyperglycemia in individuals with type 1 d…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes [Phase 1]
Phase 1 clinical trial update evaluating the safety, tolerability, distribution, and activity of NNC0148-0000-0287 in healthy subjects and i…
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes [Phase 1]
Phase 1 pharmacokinetic and pharmacodynamic study comparing BIOD-105 and BIOD-107 to Humalog in subjects with Type 1 diabetes has completed.